Webcast
Event Title
Webinar - Notifying CDRH of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act During the COVID-19 Public Health Emergency
May 11, 2020
- Date:
- May 11, 2020
- Time:
-
2:00 PM - 3:00 PM ET
Tell us what you think about the webinar
Webinar Materials
Summary:
On May 11, 2020, from 2:00 pm - 3:00 pm Eastern Time, the U.S. Food and Drug Administration (FDA) will host a webinar for device manufacturers and industry to discuss and answer questions about the immediately in effect guidance Notifying CDRH of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act During the COVID-19 Public Health Emergency.
Background:
On May 6, 2020, the FDA issued the guidance Notifying CDRH of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act During the COVID-19 Public Health Emergency to implement section 506J of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 351 et seq.), as added by section 3121 of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), as it relates to device shortages and potential device shortages occurring during the COVID-19 pandemic, for the duration of the COVID-19 public health emergency.
Manufacturers of devices that are critical to public health during a public health emergency, or for which the FDA determines information on potential meaningful supply disruptions is needed during a public health emergency (described in Section III of the guidance) are required to notify the FDA of an interruption or permanent discontinuance in manufacturing of such devices under Section 506J of the FD&C Act.